GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Healthways, Inc. (HWAY) [hlAlert]

Rating:
Underweight
HWAY
down 12.22 %

Healthways, Inc. (HWAY) rated Underweight with price target $9 by Barclays

Posted on: Friday,  Feb 8, 2013  1:25 PM ET by Barclays

Barclays rated Underweight Healthways, Inc. (NASDAQ: HWAY) on 02/08/2013, when the stock price was $10.48. Since
then, Healthways, Inc. has gained 13.93% as of 12/31/2015's recent price of $11.94.
If you would have followed this Barclays's recommendation on HWAY, you would have lost 12.22% of your investment in 1056 days.

Healthways, Inc. provides specialized health and care support solutions in the United States. Its services include fostering wellness and disease prevention through total population screening, health risk assessments, and supportive interventions; providing access to health improvement programs, such as fitness, weight management, complementary and alternative medicine, and smoking cessation; promoting the reduction of lifestyle behaviors that lead to poor health or chronic conditions; and providing educational materials and personal interactions with trained nurses and other healthcare professionals that are designed to create and sustain healthier behaviors to members with chronic conditions. The company's services also comprise incorporating current evidence-based clinical guidelines into interventions to optimize patient health outcomes; developing care support plans providing local market resources to address acute episodic interventions; and coordinating members' care with local healthcare providers. Healthways also offers Care Support product line, which consist of programs for people with chronic diseases or conditions, including diabetes, coronary artery disease, heart failure, asthma, chronic obstructive pulmonary disease, end-stage renal disease, cancer, chronic kidney disease, depression, high-risk obesity, metabolic syndrome, acid-related stomach disorders, atrial fibrillation, decubitus ulcer, fibromyalgia, hepatitis C, inflammatory bowel disease, irritable bowel syndrome, low-back pain, osteoarthritis, osteoporosis, and urinary incontinence. In addition, it provides high-risk care management through its StatusOne product for members at risk for hospitalization due to complex conditions. The company was founded in 1981 and is headquartered in Nashville, Tennessee.

Barclays
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/8/2013 1:25 PM Sell
None
10.48 9.00
as of 12/13/2013
1 Week up  2.63 %
1 Month down  -10.60 %
3 Months up  28.14 %
1 YTD down  -30.34 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy